Edition:
India

Livzon Pharmaceutical Group Inc (1513.HK)

1513.HK on Hong Kong Stock

28.25HKD
18 Apr 2019
Change (% chg)

HK$-0.30 (-1.05%)
Prev Close
HK$28.55
Open
HK$28.00
Day's High
HK$28.50
Day's Low
HK$27.80
Volume
404,600
Avg. Vol
924,806
52-wk High
HK$49.85
52-wk Low
HK$20.05

Latest Key Developments (Source: Significant Developments)

Livzon Pharmaceutical Group Approves Appointment Of Xu Guoxiang As Vice Chairman Of Board
Thursday, 11 Apr 2019 

April 11 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::APPOINTS DAI WEIGUO AS VICE PRESIDENT.BOARD APPROVED APPOINTMENT OF XU GUOXIANG AS VICE CHAIRMAN OF BOARD.  Full Article

Livzon Pharmaceutical Group Says 2018 Net Profit Down 75.6 Percent Y/Y
Wednesday, 27 Mar 2019 

March 27 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>1513.HK::SAYS 2018 NET PROFIT DOWN 75.6 PERCENT Y/Y.  Full Article

Livzon Pharmaceutical Announces Relocation And Expansion Project Of Unit
Wednesday, 6 Mar 2019 

March 6 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::ANNOUNCEMENT ON OVERALL RELOCATION AND EXPANSION PROJECT OF A SUBSIDARY.LIVZON PHARMACEUTICAL - CO TO INJECT CAPITAL OF RMB646 MILLION FOR INVESTMENT IN & CONSTRUCTION OF OVERALL RELOCATION & EXPANSION PROJECT OF UNIT.LIVZON PHARMACEUTICAL GROUP - UPON COMMENCEMENT, PROJECT SHALL BE COMPLETED WITHIN 36 MONTHS; PUT INTO PRODUCTION WITHIN 12 MONTHS UPON CONSTRUCTION.  Full Article

Livzon Pharmaceutical Group Appoints Tang Yanggang As President
Friday, 28 Dec 2018 

Dec 28 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::TAO DESHENG HAS RESIGNED AS PRESIDENT OF CO.TAO DESHENG RE-DESIGNATED FROM EXECUTIVE DIRECTOR TO A NON-EXECUTIVE DIRECTOR.CONSIDERED AND APPROVED APPOINTMENT OF TANG YANGGANG AS PRESIDENT OF CO.TAO DESHENG WILL CONTINUE TO STAY AS VICE CHAIRMAN.PROPOSED APPOINTMENT TANG YANGGANG AS AN EXECUTIVE DIRECTOR OF CO.  Full Article

Livzon Pharmaceutical Group Reports Accident At Unit's Refining Workshop
Wednesday, 31 Oct 2018 

Oct 31 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::FIRE BROKE OUT IN 201-2 REFINING WORKSHOP OF LIVZON GROUP (NINGXIA) PHARMACEUTICAL MANUFACTURING CO., ON OCT 30.WORKSHOP WHERE ACCIDENT OCCURRED HAS BEEN SHUT DOWN, OTHER WORKSHOPS IN FACTORY AREA IN NORMAL PRODUCTION.ACCIDENT DID NOT CAUSE CASUALTIES, CAUSE OF ACCIDENT & PROPERTY DAMAGE STILL UNDER FURTHER INVESTIGATION.  Full Article

Livzon Pharmaceutical Sees H1 Net Profit Up About 20-30 Percent Y/Y
Thursday, 12 Jul 2018 

July 12 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>1513.HK::SAYS IT SEES 6-MONTH NET PROFIT UP ABOUT 20-30 PERCENT Y/Y FROM 504.0 MILLION YUAN ($75.61 million) YEAR AGO.  Full Article

Livzon Pharmaceutical Group receives approval for drug clinical trial in U.S.
Friday, 18 May 2018 

May 18(Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says it received approval for drug clinical trial for Shenqi Fuzheng Injection, from U.S Food and Drug Administration .  Full Article

Livzon Pharmaceutical's 2017 Net Profit Up 464.6 Percent Y/Y
Friday, 23 Mar 2018 

March 23 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>1513.HK::SAYS 2017 NET PROFIT UP 464.6 PERCENT Y/Y.  Full Article

BRIEF-Livzon Pharmaceutical Unit's JV Livzon Biologics' Capital Will Be Boosted By 600 Mln Yuan (Feb 7)
Wednesday, 7 Feb 2018 

Corrects currency unit in headline and bullet point to yuan, not U.S. dollar:SAYS CAPITAL AT UNIT'S JV LIVZON BIOLOGICS WILL BE BOOSTED BY 600 MILLION YUAN ($94.94 million).  Full Article

Livzon Pharmaceutical Group To Sell 51% Stake In Livzon Mab To Biologics Ltd
Wednesday, 7 Feb 2018 

Feb 7 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::‍APPROVED TRANSACTION IN RESPECT OF CHANGE IN SHAREHOLDING STRUCTURE OF LIVZON MABPHARM INC​.CO TO SELL 51% EQUITY INTERESTS IN LIVZON MAB TO BIOLOGICS LIMITED.‍LIVZON INTERNATIONAL & JOINCARE BVI TO CONTRIBUTE TO LIVZON BIOLOGICS RMB306 MILLION AND RMB294 MILLION RESPECTIVELY​.‍BIOLOGICS LIMITED AGREED TO ACQUIRE 49% EQUITY INTERESTS IN LIVZON MAB FROM JOINCARE​.  Full Article